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Erythritol, a naturally occurring polyol, is gaining attention as a bulk sweetener for human nutrition. Industrially, it is produced from glucose by fermenta-
tion. From various studies it is known to be non-cariogenic. Moreover, it is rapidly absorbed in the small intestine and quantitatively excreted in the urine.
Only about 10 % enters the colon. Earlier in vitro experiments showed that erythritol remained unfermented for a fermentation period of 12 h. In order to
investigate whether fresh human intestinal microbiota is able to adapt its enzyme activities to erythritol, a 24 h lasting fermentation was carried out under
well-standardised in vitro conditions. For comparison maltitol, lactulose and blank (faecal inoculum only) were incubated as well. Fermentation patterns
were established by following total gas production, hydrogen accumulation, changes in pH value, SCFA production and substrate degradation. Taking
all fermentation parameters into account, erythritol turned out to be completely resistant to bacterial attack within 24 h, thus excluding an adaptation
within that period. Since under in vivo conditions more easily fermentable substrates enter the colon continuously, it seems very unlikely that erythritol
will be fermented in vivo.
Erythritol: Maltitol: Lactulose: In vitro fermentation
Polyols (sugar alcohols) are being used as bulk sweeteners in
human nutrition. Maltitol, sorbitol, lactitol, mannitol, isomalt
and xylitol have a long history of use. Until some time ago ery-
thritol was only available in Japan. However, recently erythritol
has been launched on the American market and it obtained a posi-
tive evaluation from the European Commission’s Scientific Com-
mittee of Food (2003), opening the doors for future use in Europe.
Erythritol, a four-carbon sugar alcohol, occurs widely in nature
and also in foods like wine, beer, mushroom, pear, grape and
soy sauce (Bernt et al. 1996). Industrially, it is produced from glu-
cose by an osmophilic yeast (Goossens & Ro¨per, 1994). Sub-
sequent separation and purification yield a crystalline product
with a purity of 99 %. Erythritol is not metabolised by oral
micro-organisms. In vitro incubation with a range of Streptococci
species showed that neither lactic acid nor other organic acids are
produced. Additionally, Streptococci were unable to grow on ery-
thritol as sole C-source (Kawanabe et al. 1992).
In man, up to 90 % of erythritol is rapidly absorbed in the small
intestine by passive diffusion. It is distributed widely through tis-
sues but its metabolism is minimal. Being poorly reabsorbed by
the kidneys it is quantitatively excreted in the urine (Bernt et al.
1996). Neither plasma glucose nor insulin levels are affected by
oral erythritol intake (Bornet et al. 1996; Ishikawa et al. 1996).
Mean glycaemic and insulinaemic indices of 0 and 2, respect-
ively, have been reported (Livesey, 2003). Moreover, no effect
on NEFA homeostasis has been observed (Ishikawa et al.
1996). All these observations indicate that erythritol is neither
entering carbohydrate- nor fat-metabolic pathways. Compared to
other polyols ingested in comparable amounts, erythritol leads
to clearly lower osmotic pressures and to rarely any gas pro-
duction (Oku & Okazaki, 1996). This is due to the fact that
only a small fraction of erythritol enters the colon. Theoretically,
each gram of polyol being completely absorbed is fully available
as energy, whereas total fermentation would result in an energy
contribution of approximately 50 % via SCFA that are absorbed
by the colonic epithelium (Livesey, 2003). Based on both the neg-
ligible metabolism and the small amount reaching the large intes-
tine, the energy value of erythritol was confirmed to be less than
0·9 kJ/g by the European Commission’s Scientific Committee on
Food (2003).
The relatively small unabsorbed fraction of erythritol enters the
colon, where it may be subject to fermentation by the colonic
microbiota (Bernt et al. 1996). Early animal experiments (Noda &
Oku, 1992) suggest that 10 % of supplied erythritol may be
susceptible to fermentation in rats. Data from human faecal inocu-
late are scarce. Hiele et al. (1993) studied the metabolic fate of
25 g 13C-labelled orally ingested erythritol in six healthy human
volunteers. No increase in breath 13CO2 and H2 was observed,
indicating that the polyol absorbed is neither metabolised endogen-
ously nor by colonic bacteria. Indeed, a high proportion of erythritol
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(84·1 (SE 3·3) %) was recovered unchanged from urine, leaving the
possibility that the remainder was either excreted with faeces or con-
verted to non-oxidised compounds by colonic bacteria. In order to
check the latter possibility, the authors performed an in vitro fer-
mentation experiment under strict anaerobic conditions, using
fresh faecal microbiota from six volunteers. After 6 h the H2 concen-
tration was measured in the headspace of the vials. No H2 produc-
tion from erythritol was observed. The authors concluded that
erythritol is not metabolised by human faecal bacteria but raised
the point that some metabolism may occur after a longer adaptation
period. In another, non-published, experiment (Barry et al. 1992),
erythritol was introduced in fermentation flasks placed in a water
bath at 388C. For this experiment a fresh human inoculate from
three healthy volunteers was used. Gas and SCFA production as
well as erythritol disappearance were monitored during the 12 h last-
ing fermentation period. Neither gas nor SCFA were produced and
the polyol was recovered virtually completely after fermentation.
Therefore, the authors concluded that erythritol is non-fermentable.
Since both known in vitro experiments using fresh human
faecal microbiota showed no degradation of erythritol within
12 h, the aim of the present study was to prolong the fermentation
period to 24 h and thus to check whether colonic bacteria are able
to adapt their enzyme activities within this period. For compari-
son, maltitol was chosen as a second substrate. This disacchar-
ide-type polyol is characterised by a lower absorption, but a
higher fermentation rate (approximately 40 and 60 %, respect-
ively) compared to erythritol (Livesey, 2003), thus being expected
to be better fermentable. In addition, lactulose as a very easily fer-
mentable substrate and a blank (faecal inoculum only) were
included to standardise the experiment.
Materials and methods
Substrates
Erythritol and maltitol (purity on DM basis: $99·8 % and
$99·0 %, respectively) were obtained from Cerestar-Cargill
R&D Center (Vilvoorde, Belgium). Lactulose was purchased
from Fluka Chemie (Buchs, Switzerland) and was $98·0 % pure.
Methodology
In vitro fermentation was carried out by applying a well-standar-
dised batch technique (Lebet et al. 1998). Incubations were
performed under strictly anaerobic conditions with a mixture of
freshly collected human faeces of four non-methanogenic individ-
uals. Duplicate samples were taken at 0, 6 and 24 h. HgCl2 was
used to stop fermentation. pH, total gas, H2 and SCFA production
in an acidified aliquot of the supernatant were determined as
described in the standard procedure. The residues were freeze-
dried and ground in a ball mill. To determine substrate disappear-
ance residual polyols were quantified by HPLC, based on ISO
International Standard (1998) method 10504.
Results
Total gas production and H2 accumulation can be followed in
Fig. 1(A and B). Values obtained for lactulose (easily fermentable
substrate as positive control) and blanks (endogenous fermentabil-
ity of inoculum as negative control) were found to be in agree-
ment with overall mean values obtained with the same
fermentation system. Compared to the blank, virtually no
additional gas was produced when fermenting erythritol. More-
over, no H2 accumulation could be observed. Maltitol showed a
clearly lower total gas production during the first 6 h as well as
an intermediate H2 accumulation compared to lactulose. By the
end of the incubation, however, almost identical amounts in
total gas were produced.
Fig. 1. Total gas production (A), hydrogen accumulation (B) and substrate
disappearance (C) during in vitro fermentation of erythritol (†) compared to
maltitol (O), lactulose (A) and blank (W). For details of procedures, see
p. 644. Values are means of duplicates with standard deviation ,5% (except
where indicated: *10%).
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When looking at changes in pH values and SCFA production
(Table 1), similar observations were made. Erythritol and
blanks did not differ in any parameter, whereas maltitol and lac-
tulose reached similar end values. As also seen for gas production,
SCFA formation and thus pH drop was found to be considerably
slower for maltitol compared to lactulose within the first 6 h of
fermentation. Although the total SCFA production reached com-
parable end values for both substrates, it has to be mentioned
that qualitative differences were observed. Significantly higher
amounts of propionate and butyrate were produced from maltitol.
Substrate disappearance can be followed in Fig. 1(C). Erythri-
tol turned out to be completely resistant to the attack by the colo-
nic microbiota during the 24 h of fermentation. In contrast,
maltitol degradation was found to be linear but complete within
that period. Lactulose disappearance was not determined in the
present study. However, its complete degradation within 6 h
was shown in earlier experiments (Arrigoni et al. 2004).
Discussion
Gas production from erythritol turned out to be negligible. Similar
in vitro results were also observed by Hiele et al. (1993), who
showed that H2 formation by faecal bacteria after 6 h of incu-
bation with erythritol was not higher than after the blank incu-
bation. Moreover, Barry et al. (1992) reported neither total gas
nor H2 production over a fermentation period of 12 h. The fact
that gas production from maltitol is retarded compared to that
from lactulose is in accordance with in vivo results by Storey
et al. (1998). They found significantly lower breath H2 values
(cumulated over a period of 6 h after ingestion) from maltitol.
SCFA production as well as the concomitant pH drop reflects
the observations made for gas production. No published data
are available for total SCFA production from erythritol. However,
the changes in pH values observed in the present study confirm
observations made by Barry et al. (1992) for both erythritol and
maltitol. As can be seen from substrate disappearance data, ery-
thritol turned out to be completely resistant to the attack by
faecal bacteria, a fact which has already been reported for a
period of 12 h (Barry et al. 1992). However, the present
experiment showed that erythritol is even not susceptible to the
colonic microbiota within 24 h. The nearly linear degradation of
maltitol is in accordance with results obtained by Barry et al.
(1992), who also found a retarded metabolisation of the substrate.
Taking all fermentation parameters into account, it can be
stated that erythritol as a sole substrate is completely non-fermen-
table by freshly collected human faecal microbiota within a
period of 24 h. Based on the currently obtained data, the contri-
bution to daily energy intake by gut fermentation of erythritol
after oral intake in man is considered to be nil. For verification
in vivo, a complete balance study would be required. Erythritol
determination in faeces is rather simple, but a quantification of
the absolute amount entering the colon is very complex. Although
its total resistance to faecal bacterial fermentation in vivo is not
definitively proven, it seems very likely that erythritol is excreted
unchanged in man. The latter is supported by the fact that undi-
gested dietary substrates as well as endogenous sources enter
the colon continuously in considerable amounts (Gibson et al.
1996), most of them being more easily fermentable.
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